DOJ Attys Dish On Pharma, Device Fraud Landscape

Attorneys at the U.S. Department of Justice this week pulled back the curtain on hot enforcement topics involving drug and device sales, dishing on the legal wrangling behind Wyeth's $785 million...

Already a subscriber? Click here to view full article